tradingkey.logo
tradingkey.logo

aTyr Pharma Ord Shs

LIFE
10.130USD
+0.030+0.30%
Cierre 03/27, 16:00ETCotizaciones retrasadas 15 min
633.72MCap. mercado
8.91P/E TTM

aTyr Pharma Ord Shs

10.130
+0.030+0.30%

Más Datos de aTyr Pharma Ord Shs Compañía

Ethos Technologies Inc. is a United States-based life insurance company. The Company offers whole life insurance and term life insurance. Its whole life insurance provides accidental death benefit and death benefit. Its term life insurance offers monthly payment of premiums that do not increase during the term. It is provided for age 65-85 years. Its term life insurance provides coverage for a term typically 10-30 years. The Company operates in every United States and the District of Columbia.

Información de aTyr Pharma Ord Shs

Símbolo de cotizaciónLIFE
Nombre de la empresaEthos Technologies Inc
Fecha de salida a bolsaMay 07, 2015
Director ejecutivoColis (Peter George)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 07
Dirección1606 Headway Circle
CiudadAUSTIN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal78754
Teléfono13026365400
Sitio Webhttps://www.ethos.com/
Símbolo de cotizaciónLIFE
Fecha de salida a bolsaMay 07, 2015
Director ejecutivoColis (Peter George)

Ejecutivos de aTyr Pharma Ord Shs

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%
Mr. Timothy P. (Tim) Coughlin, CPA
Mr. Timothy P. (Tim) Coughlin, CPA
Independent Chairman of the Board
Independent Chairman of the Board
56.00K
+89.29%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
9.75K
+38.46%
Dr. Svetlana Lucas, Ph.D.
Dr. Svetlana Lucas, Ph.D.
Independent Director
Independent Director
6.00K
--
Dr. Paul R. Schimmel, Ph.D.
Dr. Paul R. Schimmel, Ph.D.
Independent Director
Independent Director
--
--
Ms. Jill M. Broadfoot
Ms. Jill M. Broadfoot
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nancy E. Denyes, J.D.
Ms. Nancy E. Denyes, J.D.
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Dr. Sara A. Zaknoen, M.D.
Dr. Sara A. Zaknoen, M.D.
Independent Director
Independent Director
--
--
Mr. Peter Colis
Mr. Peter Colis
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
--
--
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, Director, President
Co-Founder, Director, President
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%
Mr. Timothy P. (Tim) Coughlin, CPA
Mr. Timothy P. (Tim) Coughlin, CPA
Independent Chairman of the Board
Independent Chairman of the Board
56.00K
+89.29%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
9.75K
+38.46%
Dr. Svetlana Lucas, Ph.D.
Dr. Svetlana Lucas, Ph.D.
Independent Director
Independent Director
6.00K
--
Dr. Paul R. Schimmel, Ph.D.
Dr. Paul R. Schimmel, Ph.D.
Independent Director
Independent Director
--
--
Ms. Jill M. Broadfoot
Ms. Jill M. Broadfoot
Chief Financial Officer
Chief Financial Officer
--
--

Desglose de ingresos

La empresa aún no ha revelado los datos relevantes.
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: vie., 20 de feb
Actualizado: vie., 20 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
15.00%
Federated Hermes Global Investment Management Corp.
10.76%
BlackRock Institutional Trust Company, N.A.
6.10%
The Vanguard Group, Inc.
5.06%
State Street Investment Management (US)
4.28%
Otro
58.79%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
15.00%
Federated Hermes Global Investment Management Corp.
10.76%
BlackRock Institutional Trust Company, N.A.
6.10%
The Vanguard Group, Inc.
5.06%
State Street Investment Management (US)
4.28%
Otro
58.79%
Tipos de accionistas
Accionistas
Proporción
Venture Capital
24.49%
Individual Investor
12.09%
Investment Advisor
10.75%
Investment Advisor/Hedge Fund
0.79%
Otro
51.88%

Participación institucional

Actualizado: vie., 30 de ene
Actualizado: vie., 30 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
240
61.49M
62.75%
-12.15M
2025Q4
244
60.50M
61.75%
-16.64M
2025Q3
241
62.16M
63.44%
-11.39M
2025Q2
207
66.51M
74.72%
-166.29K
2025Q1
151
62.77M
70.80%
+2.91M
2024Q4
133
55.86M
66.65%
-3.11M
2024Q3
108
48.56M
65.39%
-7.43M
2024Q2
103
48.81M
71.98%
+527.76K
2024Q1
101
42.52M
63.83%
-4.61M
2023Q4
100
41.92M
72.67%
-1.23M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
14.70M
15%
+1.35M
+10.09%
Sep 30, 2025
Federated Hermes Global Investment Management Corp.
10.54M
10.76%
-4.12M
-28.11%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
5.98M
6.1%
+635.14K
+11.89%
Sep 30, 2025
The Vanguard Group, Inc.
4.96M
5.06%
-669.06K
-11.88%
Dec 31, 2025
State Street Investment Management (US)
4.20M
4.28%
+2.96M
+238.49%
Sep 30, 2025
GSA Capital Partners LLP
706.73K
0.72%
+210.44K
+42.40%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.18M
2.22%
+80.13K
+3.82%
Sep 30, 2025
Millennium Management LLC
1.89M
1.93%
+290.72K
+18.17%
Sep 30, 2025
UBS Financial Services, Inc.
4.34M
4.43%
+2.59M
+148.61%
Sep 30, 2025
Schimmel (Paul R Ph.D.)
1.10M
1.12%
+100.00K
+9.99%
Mar 01, 2025
Ver más

ETFs relacionados

Actualizado: vie., 30 de ene
Actualizado: vie., 30 de ene
Nombre
Proporción
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Invesco Dorsey Wright SmallCap Momentum ETF
0%
iShares Russell 2000 Value ETF
0%
Vanguard US Momentum Factor ETF
0%
Pacer WealthShield ETF
0%
Direxion Daily S&P Biotech Bull 3X Shares
0%
Avantis US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
Ver más
iShares Micro-Cap ETF
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0%
Global X Russell 2000 ETF
Proporción0%
Invesco Dorsey Wright SmallCap Momentum ETF
Proporción0%
iShares Russell 2000 Value ETF
Proporción0%
Vanguard US Momentum Factor ETF
Proporción0%
Pacer WealthShield ETF
Proporción0%
Direxion Daily S&P Biotech Bull 3X Shares
Proporción0%
Avantis US Small Cap Equity ETF
Proporción0%
ProShares UltraPro Russell2000
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI